Shukra Pharmaceuticals Faces Intense Selling Pressure Amid Consecutive Losses

Shukra Pharmaceuticals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past three days, resulting in a total decline of 5.8% during this period. Today, Shukra Pharmaceuticals reported a performance drop of 1.99%, underperforming the Sensex, which fell by 0.87%.
In the past week, the stock has decreased by 1.22%, while the Sensex has seen a decline of 1.99%. Over the last month, Shukra Pharmaceuticals has suffered a substantial loss of 28.85%, contrasting sharply with the Sensex's gain of 1.62%. The stock's performance over three months shows a decline of 28.65%, compared to the Sensex's increase of 7.41%.

Despite a year-to-date performance of 1.27%, which is lower than the Sensex's 3.52%, Shukra Pharmaceuticals has shown remarkable growth over longer periods, with a three-year increase of 4561.49% and a five-year increase of 8498.86%. However, the current trend indicates a struggle against broader market movements, with the stock trading below its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains above the 200-day moving average.